These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21545053)

  • 21. Biocatalysis: synthesis of chiral intermediates for drugs.
    Patel RN
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):741-64. PubMed ID: 17117684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in fluorination techniques and their anticipated impact on drug metabolism and toxicity.
    Murphy CD; Sandford G
    Expert Opin Drug Metab Toxicol; 2015 Apr; 11(4):589-99. PubMed ID: 25728479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An advancement in drug research: rational drug design with combinatorial chemistry].
    Pindur U
    Pharm Unserer Zeit; 1997 Jan; 26(1):24-30. PubMed ID: 9157462
    [No Abstract]   [Full Text] [Related]  

  • 24. Crystal structures of drugs: advances in determination, prediction and engineering.
    Datta S; Grant DJ
    Nat Rev Drug Discov; 2004 Jan; 3(1):42-57. PubMed ID: 14708020
    [No Abstract]   [Full Text] [Related]  

  • 25. Forewords BMC.
    Gallou F
    Bioorg Med Chem; 2018 Aug; 26(14):4329. PubMed ID: 29983282
    [No Abstract]   [Full Text] [Related]  

  • 26. Fluorine in pharmaceuticals: looking beyond intuition.
    Müller K; Faeh C; Diederich F
    Science; 2007 Sep; 317(5846):1881-6. PubMed ID: 17901324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent In Silico Resources for Drug Design and Discovery.
    Veljkovic N
    Curr Med Chem; 2019; 26(21):3836-3837. PubMed ID: 31584358
    [No Abstract]   [Full Text] [Related]  

  • 28. The impact of microwave synthesis on drug discovery.
    Kappe CO; Dallinger D
    Nat Rev Drug Discov; 2006 Jan; 5(1):51-63. PubMed ID: 16374514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthetic approaches to the 2013 new drugs.
    Ding HX; Leverett CA; Kyne RE; Liu KK; Fink SJ; Flick AC; O'Donnell CJ
    Bioorg Med Chem; 2015 May; 23(9):1895-922. PubMed ID: 25797159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chirality and its importance in drug development.
    Campbell DB; Wilson K
    Biochem Soc Trans; 1991 Apr; 19(2):472-5. PubMed ID: 1889635
    [No Abstract]   [Full Text] [Related]  

  • 31. Structure-Based Drug Design Strategies and Challenges.
    Wang X; Song K; Li L; Chen L
    Curr Top Med Chem; 2018; 18(12):998-1006. PubMed ID: 30101712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthetic Approaches to the New Drugs Approved During 2017.
    Flick AC; Leverett CA; Ding HX; McInturff E; Fink SJ; Helal CJ; O'Donnell CJ
    J Med Chem; 2019 Aug; 62(16):7340-7382. PubMed ID: 30939001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural product hybrids as new leads for drug discovery.
    Tietze LF; Bell HP; Chandrasekhar S
    Angew Chem Int Ed Engl; 2003 Sep; 42(34):3996-4028. PubMed ID: 12973759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. March of the synthesis machines.
    Sanderson K
    Nat Rev Drug Discov; 2015 May; 14(5):299-300. PubMed ID: 25924572
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthetic Approaches to New Drugs Approved During 2016.
    Flick AC; Ding HX; Leverett CA; Fink SJ; O'Donnell CJ
    J Med Chem; 2018 Aug; 61(16):7004-7031. PubMed ID: 29620889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Foreword.
    Moribe K; Yonemochi E
    Chem Pharm Bull (Tokyo); 2019; 67(9):904-905. PubMed ID: 31474727
    [No Abstract]   [Full Text] [Related]  

  • 37. De novo drug design.
    Hartenfeller M; Schneider G
    Methods Mol Biol; 2011; 672():299-323. PubMed ID: 20838974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of Highly Chemoselective Oxidative Transformations by Designing Organoradicals.
    Oisaki K
    Chem Pharm Bull (Tokyo); 2018; 66(10):907-919. PubMed ID: 30270237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlling chirality in enzymatic synthesis.
    Hodgson J
    Biotechnology (N Y); 1992 Oct; 10(10):1093-7. PubMed ID: 1368788
    [No Abstract]   [Full Text] [Related]  

  • 40. Race for molecular summits.
    Service RF
    Science; 1999 Jul; 285(5425):184-5, 187. PubMed ID: 10428711
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.